Inside the Investment Lens: Patterns from 500 Healthtech Deals
Webinar Overview
Most healthtech companies don’t fail because of the tech. They fail because no one actually uses them.
After reviewing 500+ deals, we’ve found the same patterns come up again and again. Some build conviction quickly. Others fall apart under closer scrutiny.
In this session, we’ll walk through how we evaluate that from an investor lens, and where clinical insight actually changes the outcome.
If you joined or saw our recent deal debate, this builds on it. This time, we’re stepping back and showing how we think across a much broader set of opportunities.
What You’ll Learn
The few questions that matter most when evaluating a healthtech opportunity
Why workflow fit and behavior change matter more than the technology itself
How clinicians identify what will actually get used in practice
Where strong companies still fall apart during evaluation
Why This is Different
Most conversations about investing focus on market size, team, and product.
We focus on what actually determines success in healthcare:
Will it get used?
Does it fit into real workflows?
Does it make sense in the context of how care is delivered and paid for?
This session builds on our Deal Debate and shifts from what we review to how we think.
Who This Is For
Physicians and clinicians interested in investing or shaping healthcare innovation
Healthcare professionals who want to understand how capital gets allocated in early-stage healthtech
Operators evaluating early-stage opportunities from an investor lens
This session will be recorded. If you can't make it live, RSVP anyway to receive the recording.
About the Speakers
Paul Slosar, MD, MHCDS is an orthopedic spine surgeon who practiced for 28 years, including 13 years as president and administrative partner, in the San Francisco Bay area. Dr. Slosar also has extensive experience as a Health Tech operator and advisor with multiple successful exits. He currently works full-time as a med-tech executive and strategic consultant for healthcare companies. Dr. Slosar holds a Master of Health Care Delivery Science from Dartmouth College, an MD from Rush University, and an Intensive Seminar Certificate in Value-Based Health Care from Harvard Business School.
Tracy Poole is an attorney with over 30 years of experience in complex commercial transactions, M&A, financing, energy, hedge fund and venture capital disciplines. Tracy was corporate and outside counsel to leading energy marketing and trading companies and helped close some of the largest wholesale energy transactions in existence. He is the former General Counsel of a large energy-related hedge fund and the founder and operator of an independent upstream oil and gas producer with multiple exits. Tracy has been investing in early-stage companies for more than 20 years.